Profusa (NASDAQ: PFSA) Receives Nasdaq Listing Transfer Approval

May 8, 2026

Expert Analysis Profusa (NASDAQ: PFSA) is navigating an important transitional phase in its market listing status, reflecting broader challenges and strategic decisions faced by emerging digital health companies seeking to maintain public market visibility. The company’s ability to comply with Nasdaq Capital Market requirements will be crucial in sustaining investor confidence and supporting its growth trajectory. Maintaining a listing on Nasdaq is not only a regulatory milestone but also a…

Read More >>